AdamDSimmonsMD

Movement Disorder

Physician

Dr. Simmons is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
300 Carew St
Suite # 2
Springfield, MA 01104
Phone+1 413-781-5050

Fax+1 413-781-2510

Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 2002 - 2005
The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 2001 - 2002
Perelman School of Medicine at the University of PennsylvaniaClass of 2001

PubMed

7 citations
Efficacy and Safety of Ravulizumab, a Complement C5 Inhibitor, in Adults With Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Angela Genge, Leonard H van den Berg, Glen Frick, Steve Han, Cori Abikoff
JAMA Neurology. 2023-10-01
3 citations
Olanzapine/samidorphan combination consistently mitigates weight gain across various subgroups of patients.
Jonathan M Meyer, Adam Simmons, Ying Jiang, Christine Graham, Sergey Yagoda
CNS Spectrums. 2023-08-01
6 citations
Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis.
Christoph U Correll, Mikkel Højlund, Christine Graham, Mark S Todtenkopf, David McDonnell
The International Journal of Neuropsychopharmacology. 2023-07-31

Clinical Research Stakeholders Join the STARR Coalition to Highlight Critical Mental Health Research ImperativesApril 7th, 2021
Helping Parkinson’s Disease Patients Beyond the Use of MedicationMay 10th, 2018